Tag: Allied Corp

News from Kelowna, BC, Canada – March 16, 2022, Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) has announced that it has successfully filed for a full patent regarding “DOSING REGIMES OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH”. The timestamp of the previous…